Sionna Therapeutics (SION) News Today $25.72 +0.59 (+2.35%) As of 08/28/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock SION Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Elena Ridloff Sells 3,618 Shares of Sionna Therapeutics (NASDAQ:SION) Stock2 hours ago | insidertrades.comSionna Therapeutics to Participate in Upcoming September Investor ConferencesAugust 27 at 7:00 AM | globenewswire.comSionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of ...August 26 at 12:06 AM | markets.businessinsider.comAtlas Venture Life Science Advisors LLC Invests $38.64 Million in Sionna Therapeutics, Inc. $SIONAugust 25, 2025 | marketbeat.comSionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic FibrosisAugust 25, 2025 | globenewswire.comSionna Therapeutics: A Differentiated Bet In The $12 Billion Cystic Fibrosis MarketAugust 22, 2025 | seekingalpha.comAberdeen Group plc Invests $7.80 Million in Sionna Therapeutics, Inc. $SIONAugust 22, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Upgraded to "Hold" at Wall Street ZenAugust 17, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Shares Gap Up After Strong EarningsAugust 12, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Releases Quarterly Earnings Results, Beats Expectations By $0.27 EPSAugust 12, 2025 | marketbeat.comSionna Therapeutics, Inc. (SION) - Yahoo FinanceAugust 12, 2025 | finance.yahoo.comSionna Therapeutics reports Q2 EPS (41c) vs ($2.71) last yearAugust 11, 2025 | msn.comSionna Therapeutics Reports Second Quarter 2025 Financial ResultsAugust 11, 2025 | globenewswire.comCenterBook Partners LP Purchases New Shares in Sionna Therapeutics, Inc. (NASDAQ:SION)August 9, 2025 | marketbeat.com55,366 Shares in Sionna Therapeutics, Inc. (NASDAQ:SION) Acquired by TD Asset Management IncAugust 5, 2025 | marketbeat.comSionna Therapeutics, Inc.'s Lock-Up Period To Expire on August 6th (NASDAQ:SION)July 30, 2025 | marketbeat.comHere's Why We're Not Too Worried About Sionna Therapeutics' (NASDAQ:SION) Cash Burn SituationJuly 28, 2025 | finance.yahoo.comJennison Associates LLC Buys New Position in Sionna Therapeutics, Inc. (NASDAQ:SION)July 21, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Trading Down 6.6% - Time to Sell?July 15, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Shares Gap Down - Here's WhyJuly 10, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Trading Down 3% - Should You Sell?July 10, 2025 | marketbeat.comSION - Sionna Therapeutics Inc News - MorningstarJuly 2, 2025 | morningstar.comMSionna Therapeutics (NASDAQ:SION) Shares Gap Up on Insider Buying ActivityJuly 2, 2025 | marketbeat.comTpg Gp A, Llc Acquires 60,000 Shares of Sionna Therapeutics, Inc. (NASDAQ:SION) StockJuly 2, 2025 | insidertrades.comSionna Therapeutics, Inc. (NASDAQ:SION) Major Shareholder Purchases $950,400.00 in StockJuly 1, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Trading 7.5% Higher - Here's WhyJune 30, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Shares Down 10% - Here's WhyJune 25, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Trading 8.3% Higher - Here's WhyJune 24, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Shares Gap Down - Should You Sell?June 16, 2025 | marketbeat.comSionna Therapeutics reports annual meeting resultsJune 15, 2025 | investing.comSionna Therapeutics (NASDAQ:SION) Trading Up 6.5% - Should You Buy?June 10, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Stock Price Down 5.3% - Should You Sell?June 9, 2025 | marketbeat.comStifel analysts reiterate buy rating on Sionna Therapeutics stockJune 6, 2025 | uk.investing.comSionna Therapeutics Announces Positive Phase 1 Results For SION-719, SION-451 In Cystic FibrosisJune 6, 2025 | nasdaq.comSionna Therapeutics Shares Rise on Positive Data for its Cystic Fibrosis TreatmentJune 6, 2025 | marketwatch.comSionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE ModelJune 6, 2025 | globenewswire.comSionna Therapeutics (NASDAQ:SION) Shares Gap Up - Here's WhyJune 4, 2025 | marketbeat.comSionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic FibrosisJune 4, 2025 | globenewswire.comSionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare ConferenceJune 3, 2025 | globenewswire.comSionna Therapeutics (NASDAQ:SION) Stock Price Down 6% - Here's WhyMay 31, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Stock Price Up 6.8% - Here's WhyMay 30, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Stock Rating Lowered by Wall Street ZenMay 24, 2025 | marketbeat.comSionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis ConferenceMay 22, 2025 | globenewswire.comSionna Therapeutics (NASDAQ:SION) Shares Gap Down After Earnings MissMay 15, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Issues Quarterly Earnings ResultsMay 14, 2025 | marketbeat.comSionna Therapeutics, Inc.: Sionna Therapeutics Reports First Quarter 2025 Financial ResultsMay 12, 2025 | finanznachrichten.deSionna Therapeutics Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comWhile individual investors own 26% of Sionna Therapeutics, Inc. (NASDAQ:SION), private equity firms are its largest shareholders with 56% ownershipMay 9, 2025 | uk.finance.yahoo.comSionna Therapeutics (NASDAQ:SION) Trading Down 6.6% - Here's What HappenedMay 7, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Shares Gap Down - What's Next?April 30, 2025 | marketbeat.com Get Sionna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SION and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SION Media Mentions By Week SION Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SION News Sentiment▼-0.461.03▲Average Medical News Sentiment SION News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SION Articles This Week▼113▲SION Articles Average Week Get the Latest News and Ratings for SION and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Sionna Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ACAD News PCVX News TLX News ADMA News LNTH News ACLX News PTCT News AKRO News ZLAB News APLS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SION) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sionna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sionna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access